| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President and CEO
1 company
Shukla Sanjay serves as a President and CEO at ATYR. Across recent SEC filings that breaks down to 12 buys and 3 sells. Those positions are worth an estimated $150K at current prices.
Historically, Shukla Sanjay's trades have earned a middling insider score of 66/100 across 12 rated trades. Over a 12-month horizon, 58.3% of those trades were profitable, with an average 12-month return of +25.2%.
The biggest single holding is ATYR (~$150K) as President and CEO. Net of sales, the recent Form 4 record there shows accumulation of 108,232 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | ATYR Atyr Pharma, Inc. | President and CEO | Sale+OE | 3,745 | $0.98 | $3,655.12 | -2.4% | -4.4% | - | |
| May 31, 2024 | ATYR Atyr Pharma Inc | President and CEO | Buy | 20,000 | $1.81 | $36,140.00 | +17.2% | +9.2% | +158.4% | |
| Dec 12, 2023 | ATYR Atyr Pharma Inc | President and CEO | Buy | 15,000 | $1.18 | $17,646.00 | +16.5% | +34.5% | +166.4% | |
| Nov 13, 2023 | ATYR Atyr Pharma Inc | President and CEO | Buy | 15,000 | $1.11 | $16,703.39 | +19.7% | +76.7% | +213.0% | |
| Jul 28, 2023 | ATYR Atyr Pharma Inc | President and CEO | Buy | 15,000 | $2.01 | $30,223.50 | +24.5% | -38.8% | +10.4% | |
| Nov 21, 2022 | ATYR Atyr Pharma Inc | President and CEO | Buy | 10,000 | $2.14 | $21,405.00 | +24.5% | +1.9% | -46.5% | |
| Jul 1, 2022 | ATYR Atyr Pharma Inc | President and CEO | Buy | 15,000 | $2.88 | $43,164.00 | +58.1% | 0.0% | -24.2% | |
| Jan 7, 2022 | ATYR Atyr Pharma Inc | President and CEO | Buy | 5,000 | $6.76 | $33,806.50 | +24.0% | -22.5% | -63.0% | |
| Nov 15, 2021 | ATYR Atyr Pharma Inc | President and CEO | Buy | 2,500 | $8.58 | $21,437.50 | +13.7% | -40.1% | -71.3% | |
| May 18, 2021 | ATYR Atyr Pharma Inc | President and CEO | Buy | 10,000 | $4.01 | $40,100.00 | +120.5% | +18.4% | -24.2% |